Logotype for Aemetis Inc

Aemetis (AMTX) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Aemetis Inc

Q1 2026 earnings summary

13 May, 2026

Executive summary

  • Revenue grew 27% year-over-year to $54.6 million, driven by gains in all operating segments and the first-time recognition of Section 45Z production tax credits as revenue.

  • Gross profit turned positive at $2.8 million, reversing a $5.1 million loss in Q1 2025, mainly due to lower corn costs, increased biodiesel sales, and tax credit income.

  • Operating loss improved by 60% to $6.3 million from $15.6 million, and net loss narrowed to $21.7 million from $24.5 million year-over-year.

  • Adjusted EBITDA improved to negative $1.3 million from negative $10.7 million in Q1 2025.

  • Major capital projects advanced, including dairy biogas pretreatment and the $40 million MVR project at the Keyes ethanol plant.

Financial highlights

  • California Ethanol segment revenue rose 2.9% to $38.8 million; gross profit improved to $0.6 million from a loss.

  • Dairy RNG sales volume increased 55% to 110,000 MMBtu, with revenue more than doubling to $5.3 million.

  • India Biodiesel revenue rebounded to $10.5 million, up 291%, with gross profit of $0.1 million.

  • Section 45Z Production Tax Credits contributed $4.0 million in Q1 2026.

  • Cash and equivalents stood at $4.8 million at quarter-end; total debt increased to $404.7 million.

Outlook and guidance

  • Focus for 2026 is on scaling production, monetizing renewable fuel credits, completing the India IPO, and refinancing debt.

  • Key catalysts include the updated 45ZCF-GREET model, MVR commissioning, rising LCFS prices, and India IPO progress.

  • RNG segment to expand with new digesters and expects higher LCFS credit prices due to regulatory changes.

  • Substantial doubt remains about ability to continue as a going concern due to high debt and negative cash flow.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more